Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Exyte completes acquisition of Kinetics 2024-10-16 17:00
SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA 2024-10-16 14:00
Frost & Sullivan grants the 2024 Global Pluripotent stem cell drug R&D Innovation Award to ZEPHYRM BIOTECHNOLOGIES 2024-10-16 13:35
Mintel Announces Global Food and Drink Trends for 2025 2024-10-16 11:00
Mintel Announces Global Beauty and Personal Care Trends for 2025 2024-10-16 11:00
The First MINISH Seminar Held in Jakarta 2024-10-16 08:15
Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing 2024-10-16 06:12
Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge 2024-10-16 06:00
AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors 2024-10-16 05:00
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members 2024-10-16 03:00
RLDatix Appoints Dan Michelson as Chief Executive Officer 2024-10-15 23:28
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting 2024-10-15 22:08
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne 2024-10-15 21:50
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation 2024-10-15 21:00
Operation Smile Featured in "Beyond the Code," a New Branded Series that Explores How AI Is Driving Transformative Change 2024-10-15 21:00
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection 2024-10-15 20:50
Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies 2024-10-15 19:36
Endogenex™ Announces First Patient Enrolled in the ReCET Clinical Study 2024-10-15 19:32
1 44 45 46 47 48 1621